These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 6114045
21. The association between antihypertensive drug therapies and plasma lipid levels in the general population. Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A. J Hum Hypertens; 2001 Oct; 15(10):701-5. PubMed ID: 11607800 [Abstract] [Full Text] [Related]
22. Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade. Fliser D, Nowack R, Allendorf-Ostwald N, Kohl B, Hübinger A, Ritz E. Am J Hypertens; 1993 Apr; 6(4):320-4. PubMed ID: 8099492 [Abstract] [Full Text] [Related]
28. [Effect of exercise on serum lipoproteins in 270 healthy men (author's transl)]. Ollivier JP, L'Hour P, Muzellec JJ, Delamourd L, Boschat J, Bercovici JP. Diabete Metab; 1981 Sep; 7(3):195-8. PubMed ID: 7319117 [Abstract] [Full Text] [Related]
29. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties. Leren P. Am J Med; 1987 Jan 05; 82(1A):31-5. PubMed ID: 2879461 [Abstract] [Full Text] [Related]
30. Effects of beta-blockers on plasma lipids during antihypertensive therapy. Lehtonen A. J Cardiovasc Pharmacol; 1985 Jan 05; 7 Suppl 2():S110-4. PubMed ID: 2409357 [Abstract] [Full Text] [Related]
31. The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids. van Brummelen P. J Cardiovasc Pharmacol; 1983 Jan 05; 5 Suppl 1():S51-5. PubMed ID: 6188920 [Abstract] [Full Text] [Related]
33. Long-term effect of sotalol on plasma lipids. Lehtonen A, Viikari J. Clin Sci (Lond); 1979 Dec 05; 57 Suppl 5():405s-407s. PubMed ID: 232028 [Abstract] [Full Text] [Related]
34. Effect of oral zinc sulphate on serum lipids and lipoproteins in human subjects. Shah DR, Singh PP, Gupta RC, Bhandari TK. Indian J Physiol Pharmacol; 1988 Dec 05; 32(1):47-50. PubMed ID: 3169959 [Abstract] [Full Text] [Related]
36. The role of multiple pharmaco-therapy in the pathogenesis of hyperlipidemia after renal transplantation. Chan MK, Varghese Z, Persaud JW, Fernando ON, Moorhead JF. Clin Nephrol; 1981 Jun 05; 15(6):309-13. PubMed ID: 6113904 [Abstract] [Full Text] [Related]
37. HDL cholesterol and beta-adrenoceptor blocking agents in a 5 year multifactorial primary prevention trial. Miettinen TA, Vanhanen H, Huttunen JK, Naukkarinen V, Mattila S, Strandberg T, Kumlin T. Br J Clin Pharmacol; 1982 Jun 05; 13(Suppl 2):431S-434S. PubMed ID: 6125196 [Abstract] [Full Text] [Related]
38. Study of serum lipids and lipoproteins of healthy subjects in Shanghai. Zhuang HZ, Hana QQ, Chen HZ. Chin Med J (Engl); 1986 Aug 05; 99(8):657-9. PubMed ID: 3100219 [No Abstract] [Full Text] [Related]
39. [Effects of reserpine as well as alpha- and beta receptor blockaders on the lipid metabolism following endotoxin]. Schmahl FW, Ohlemutz A, Huth K. Verh Dtsch Ges Inn Med; 1969 Aug 05; 75():900-3. PubMed ID: 4396077 [No Abstract] [Full Text] [Related]
40. Effect of prazosin and beta-blocker monotherapy on serum lipids: a cross-over, placebo-controlled study. Magarian EO, Dietz AJ, Freeman DS, Carlson JD. J Clin Pharmacol; 1987 Oct 05; 27(10):756-61. PubMed ID: 2892862 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]